Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 225 for “"isoniazid"”.

  1. Isoniazid hepatotoxicity

    Isoniazid (INH), one of the most effective agents in the treatment and prophylaxis of tuberculosis associated with a mild increase in liver transaminases in up to 20% of treated patients and severe hepatotoxicity in up to 2% of treated patients. Since the 1970's, a number of studies have been …

    ubc Repository record for Isoniazid hepatotoxicity (opens in a new tab) Download PDF for Isoniazid hepatotoxicity (opens in a new tab)

  2. Studies on isoniazid-induced hepatotoxicity in rabbits

    … over 2.5 million persons per year worldwide. Isoniazid is widely used in the prophylaxis and treatment of tuberculosis in this population. A major risk of isoniazid-therapy is the onset of an unpredictable and potentially fatal hepatotoxicity in 1-2% of individuals. Although the existence of …

    ubc Repository record for Studies on isoniazid-induced hepatotoxicity in rabbits (opens in a new tab) Download PDF for Studies on isoniazid-induced hepatotoxicity in rabbits (opens in a new tab)

  3. The Effect of acetaminophen on isoniazid metabolism

    … drug, causes liver necrosis in overdose. Isoniazid (INH, isonicotinyl hydrazide), an antituberculous drug, also causes liver damage in some patients at therapeutic doses. The two medications are likely to be taken concurrently. Previously we reported that, depending on the condition, INH …

    ubc Repository record for The Effect of acetaminophen on isoniazid metabolism (opens in a new tab) Download PDF for The Effect of acetaminophen on isoniazid metabolism (opens in a new tab)

  4. Isoniazid resistance in <i>Mycobacterium tuberculosis</i>

    … that 7% of TB cases globally are resistant to isoniazid (INH). INH is a key drug for the treatment of TB, alongside rifampicin (RIF). Understanding factors which influence the emergence and propagation of INH resistance and the influence of INH resistance on TB treatment success are vital in …

    the-open-u Download PDF for Isoniazid resistance in <i>Mycobacterium tuberculosis</i> (opens in a new tab)

  5. Probable mechanism of isoniazid-related hepatic injury

    This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).

    iupui Repository record for Probable mechanism of isoniazid-related hepatic injury (opens in a new tab)

  6. Controlled release of isoniazid by hybrid systems

    … modified pullulan hydrogels as drug carriers for isoniazid (INH), a first-line treatment for tuberculosis. Seven natural and synthetic clays were characterized by XRF, XRD, FTIR, BET, and TGA to explore the relationship between pore volume, surface charge, and INH adsorption/release. The clay …

    ets-quebec Download PDF for Controlled release of isoniazid by hybrid systems (opens in a new tab)

  7. Characterization of the Hepatotoxicity of Rifampicin and Isoniazid

    In a mouse model, rifampicin and isoniazid combination treatment results in cholestatic liver injury that is associated with an increase of protoporphyrin ix (PPIX), the penultimate heme precursor. Excess PPIX is believed to bind to bile acids, precipitate in bile canaliculi, and form bile plugs …

    tenn-hsc Repository record for Characterization of the Hepatotoxicity of Rifampicin and Isoniazid (opens in a new tab)

  8. Risk factors for treatment failure in isoniazid resistant tuberculosis

    … TB (resistant to at least rifampicin and isoniazid) and 170,000 deaths due to multi-drug resistant (MDR) TB worldwide. The prevalence of resistance to isoniazid is extrememly high In some regions of the world, including Vietnam, where 25% of new smear positive patients and 54% of re …

    the-open-u Download PDF for Risk factors for treatment failure in isoniazid resistant tuberculosis (opens in a new tab)

  9. Unraveling Metabolic Determinants of Isoniazid Susceptibility in Mycobacterium tuberculosis

    … cases are resistant to the frontline antibiotic isoniazid (INH), a central component of TB chemotherapeutic regimens. Resistance to INH most commonly occurs through mutations in the katG gene that reduce its ability to convert INH to its active form. We previously reported the discovery and …

    wustl Repository record for Unraveling Metabolic Determinants of Isoniazid Susceptibility in Mycobacterium tuberculosis (opens in a new tab)

  10. Transdermal delivery of isoniazid and rifampicin by pheroid technology

    … the feasibility of the transdermal delivery of isoniazid (INH) and rifampicin (RMP) by means of the novel PheroidTM technology system. The application of the latter is being investigated in combination with various actives such as peptides (insulin, human growth hormone), anti-malarial drugs …

    nwu-za Repository record for Transdermal delivery of isoniazid and rifampicin by pheroid technology (opens in a new tab)

  11. The effect of rifampin on isoniazid-induced hepatotoxicity in rabbits

    … examine the effect of rifampin pretreatment on isoniazid-induced hepatotoxicity. For more than 25 years, it has been suggested that the concomitant administration of rifampin with isoniazid potentiates the hepatotoxicity induced by isoniazid. However, evidence to support this suggestion has been …

    ubc Repository record for The effect of rifampin on isoniazid-induced hepatotoxicity in rabbits (opens in a new tab) Download PDF for The effect of rifampin on isoniazid-induced hepatotoxicity in rabbits (opens in a new tab)

  12. Comprehensive characterization of Mycobacterium tuberculosis strains after acquisition of isoniazid resistance

    … roughly 10 million new TB cases per year and isoniazid resistant (INHr) TB accounted for 9.5% of these cases around the world. In 2012, United States had an interruption in the supply of isoniazid (INH), which increased the likelihood of INH resistance rates. Although INH resistance in …

    colostate Repository record for Comprehensive characterization of Mycobacterium tuberculosis strains after acquisition of isoniazid resistance (opens in a new tab)

  13. The effect of pharmaceutical excipients on isoniazid release from chitosan beads

    … agent. Beads that consisted of 3% w/v isoniazid (lNH) and 5% w/v chitosan were prepared in a 5% w/v TPP solution (pH 8.7) as the primary beads. To improve the drug loading of chitosan isoniazid beads (ClB) the TPP concentration, pH of the TPP solution and the INH concentrations were …

    nwu-za Repository record for The effect of pharmaceutical excipients on isoniazid release from chitosan beads (opens in a new tab)

  14. Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis

    … tuberculosis treatment consists of rifampicin, isoniazid, ethambutol, and pyrazinamide taken orally over a 6 to 12 month period. Although successful when followed correctly, the drugs are relatively toxic, and drug resistance develops when treatment is not followed to completion. Simplification …

    ubc Repository record for Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis (opens in a new tab) Download PDF for Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis (opens in a new tab)

  15. Contact tracing and isoniazid preventive therapy for prevention of childhood tuberculosis in The Gambia

    … TB program activities; contact tracing and isoniazid preventive therapy (IPT) are not implemented. The burden of childhood TB is therefore poorly characterized and the operational challenges of implementing IPT are not well understood. Methods TB symptoms screening questionnaire and …

    lmu-germany Repository record for Contact tracing and isoniazid preventive therapy for prevention of childhood tuberculosis in The Gambia (opens in a new tab)

  16. Inhibition of metabolism of p-aminopropiophenone by benzhydrazide and isoniazid in the perfused liver

    This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).

    iupui Repository record for Inhibition of metabolism of p-aminopropiophenone by benzhydrazide and isoniazid in the perfused liver (opens in a new tab)

  17. Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer

    This study aimed to formulate and evaluate Isoniazid-Pyridoxine-loaded gummies for use in a population ranging from pediatric to geriatric and to study the applicability of BIO X 3D printer in printing gummy formulations. Semisolid extrusion (SSE) 3D printing is an emerging technology in …

    mississippi Repository record for Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer (opens in a new tab)

  18. Auswirkung der Isoniazid Resistenz auf die Behandlungsergebnisse einer Standard-DOTS und alternativer Therapieregime in der Kirgisischen Republik

    Unsere Studie ist für Kirgisistan und Zentralasien von großer Bedeutung, da diese die erste Untersuchung der Auswirkungen der INH-Resistenz auf die Behandlungsergebnisse einer Standard-DOTS und alternativer Therapieregime darstellt. In unserer Arbeit konnten wir zeigen, dass eine …

    lmu-germany Repository record for Auswirkung der Isoniazid Resistenz auf die Behandlungsergebnisse einer Standard-DOTS und alternativer Therapieregime in der Kirgisischen Republik (opens in a new tab)

Page 1 of 12